Alpine Immune Sciences shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Alpine Immune Sciences
Tip: Access up to 7 years of quarterly data
All positions including Alpine Immune Sciences held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Alpine Immune Sciences by Connor, Clark & Lunn Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $227k | 12k | 19.06 |
2023-09-30 | $521k | 46k | 11.45 |
2023-06-30 | $479k | 47k | 10.28 |
2023-03-31 | $419k | 54k | 7.72 |
2022-12-31 | $429k | 58k | 7.35 |
2022-09-30 | $414k | 58k | 7.20 |
2022-06-30 | $427k | 50k | 8.51 |
2022-03-31 | $254k | 28k | 8.97 |
2021-12-31 | $264k | 19k | 13.88 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management